Elevated levels of P-gp and MRP-1 have been reported in cancer cells showing an acquired multidrug-resistant phenotype following chemotherapy, whereas low levels of P-gp and MRP-1 were observed in cancer cells before chemotherapy [45, 46]. The gene discussed is PGP; the disease is cancer.